58.51
Doximity Inc stock is traded at $58.51, with a volume of 3.16M.
It is up +4.56% in the last 24 hours and up +11.32% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
See More
Previous Close:
$55.96
Open:
$55.45
24h Volume:
3.16M
Relative Volume:
1.23
Market Cap:
$11.00B
Revenue:
$550.17M
Net Income/Loss:
$201.35M
P/E Ratio:
58.51
EPS:
1
Net Cash Flow:
$232.07M
1W Performance:
-0.05%
1M Performance:
+11.32%
6M Performance:
+11.02%
1Y Performance:
+108.37%
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SAN FRANCISCO
Compare DOCS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
DOCS
Doximity Inc
|
58.51 | 11.00B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
VEEV
Veeva Systems Inc
|
281.89 | 46.43B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
70.11 | 12.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
HQY
Healthequity Inc
|
100.01 | 9.27B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
38.33 | 7.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
Dec-20-24 | Initiated | Stephens | Equal-Weight |
Dec-04-24 | Initiated | Mizuho | Neutral |
Nov-15-24 | Initiated | Goldman | Neutral |
Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
Aug-09-24 | Upgrade | Needham | Hold → Buy |
Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
Feb-26-24 | Initiated | Leerink Partners | Market Perform |
Jan-03-24 | Initiated | Barclays | Equal Weight |
Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
Aug-09-23 | Downgrade | Needham | Buy → Hold |
Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
Oct-31-22 | Initiated | Wells Fargo | Overweight |
Oct-24-22 | Initiated | Evercore ISI | In-line |
Oct-13-22 | Initiated | BTIG Research | Neutral |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
Sep-07-22 | Initiated | Truist | Hold |
Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
Jul-28-22 | Initiated | Berenberg | Buy |
May-18-22 | Reiterated | BofA Securities | Neutral |
May-18-22 | Reiterated | Goldman | Buy |
May-18-22 | Reiterated | Guggenheim | Buy |
May-18-22 | Reiterated | Jefferies | Buy |
May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
May-18-22 | Reiterated | Needham | Buy |
Apr-07-22 | Initiated | Guggenheim | Buy |
Apr-04-22 | Initiated | BofA Securities | Neutral |
Feb-11-22 | Initiated | Goldman | Buy |
Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
Dec-02-21 | Initiated | Jefferies | Buy |
Nov-17-21 | Initiated | Robert W. Baird | Outperform |
Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
Nov-10-21 | Reiterated | Goldman | Neutral |
Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
Nov-10-21 | Reiterated | Needham | Buy |
Nov-10-21 | Reiterated | Piper Sandler | Overweight |
Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
Jul-19-21 | Initiated | Canaccord Genuity | Buy |
Jul-19-21 | Initiated | Goldman | Neutral |
Jul-19-21 | Initiated | JP Morgan | Overweight |
Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
Jul-19-21 | Initiated | Piper Sandler | Overweight |
Jul-19-21 | Initiated | Raymond James | Outperform |
Jul-19-21 | Initiated | SVB Leerink | Outperform |
Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Fairvoy Private Wealth LLC Reduces Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (NYSE:DOCS) Earnings Shows Slower Q1 Growth Nasdaq Composite - Kalkine Media
Doximity (NASDAQ:DOCS) Trading Up 4.4%Should You Buy? - MarketBeat
Why Doximity Shares Are On The Rise - TipRanks
Doximity (DOCS) Shares Rise Amid Potential Policy Changes in Pharma Advertising | DOCS Stock News - GuruFocus
Rakuten Securities Inc. Lowers Stake in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Vertical Software Stocks Q1 Highlights: Doximity (NYSE:DOCS) - Yahoo Finance
Wealth Enhancement Advisory Services LLC Acquires Shares of 4,575 Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Fort Washington Investment Advisors Inc. OH Sells 34,670 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Harbor Capital Advisors Inc. Invests $1.28 Million in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
DOCS Boosts Client Retention via Workflow Integration and AI Tools - MSN
SG Americas Securities LLC Purchases Shares of 1,132,208 Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Sarasin & Partners LLP Buys New Shares in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity’s SWOT analysis: digital health leader’s stock faces macro headwinds - Investing.com Nigeria
15,791 Shares in Doximity, Inc. (NASDAQ:DOCS) Purchased by Range Financial Group LLC - MarketBeat
Wellington Management Group LLP Purchases New Shares in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Shares Acquired by GAMMA Investing LLC - MarketBeat
Rhumbline Advisers Has $19.84 Million Stock Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity: Strong Growth but What's Next? - AOL.com
Doximity Declines 4.4% in a Month: How to Play the Stock Now? - MSN
Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm - GuruFocus
Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Lmcg Investments LLC - MarketBeat
MRA Advisory Group Invests $505,000 in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
IMMINENT DOCS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Doximity, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Doximity, Inc. (NASDAQ:DOCS) Director Kira Scherer Wampler Sells 2,000 Shares - MarketBeat
Apella Capital LLC Purchases 9,719 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity Inc (DOCS) Shares Up 3.3% on Jun 5 - GuruFocus
Doximity Rides on Telehealth Demand: Will This Drive Sales Further? - MSN
6,106 Shares in Doximity, Inc. (NASDAQ:DOCS) Bought by B. Riley Wealth Advisors Inc. - MarketBeat
J2 Capital Management Inc Makes New $353,000 Investment in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (NASDAQ:DOCS) Upgraded by BTIG Research to "Buy" Rating - MarketBeat
DOCS Q1 Earnings Call: Revenue Strong Sales Highlighting Growth in AI Tools and Client Portal Adoption - Yahoo Finance
SHAREHOLDER ALERT: Morris Kandinov Investigating DV, MANH, DOCS, and SEDG; Shareholders are Encouraged to Contact the Firm - GlobeNewswire Inc.
Doximity Inc (DOCS) Trading 3.38% Higher on Jun 3 - GuruFocus
Doximity (NASDAQ:DOCS) Rating Increased to Buy at BTIG Research - Defense World
Which Telehealth Stock Should You Be Targeting? - Schaeffer's Investment Research
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):